Division of Developmental Biology, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin Biocentre, Roslin, UK.
Bone. 2010 Apr;46(4):1146-55. doi: 10.1016/j.bone.2009.12.018. Epub 2010 Jan 4.
PHOSPHO1 is a bone-specific phosphatase implicated in the initiation of inorganic phosphate generation for matrix mineralization. The control of mineralization is attributed to the actions of tissue-nonspecific alkaline phosphatase (TNAP). However, matrix vesicles (MVs) containing apatite crystals are present in patients with hypophosphatasia as well as TNAP null (Akp2(-/-)) mice. It is therefore likely that other phosphatases work with TNAP to regulate matrix mineralization. Although PHOSPHO1 and TNAP expression is associated with MVs, it is not known if PHOSPHO1 and TNAP are coexpressed during the early stages of limb development. Furthermore, the functional in vivo role of PHOSPHO1 in matrix mineralization has yet to be established. Here, we studied the temporal expression and functional role of PHOSPHO1 within chick limb bud mesenchymal micromass cultures and also in wild-type and talpid(3) chick mutants. These mutants are characterized by defective hedgehog signalling and the absence of endochondral mineralization. The ability of in vitro micromass cultures to differentiate and mineralize their matrix was temporally associated with increased expression of PHOSPHO1 and TNAP. Comparable changes in expression were noted in developing embryonic legs (developmental stages 23-36HH). Micromass cultures treated with lansoprazole, a small-molecule inhibitor of PHOSPHO1 activity, or FGF2, an inhibitor of chondrocyte differentiation, resulted in reduced alizarin red staining (P<0.05). FGF2 treatment also caused a reduction in PHOSPHO1 (P<0.001) and TNAP (P<0.001) expression. Expression analysis by whole-mount RNA in situ hybridization correlated with qPCR micromass data and demonstrated the existence of a tightly regulated pattern of Phospho1 and Tnap expression which precedes mineralization. Treatment of developing embryos for 5 days with lansoprazole completely inhibited mineralization of all leg and wing long bones as assessed by alcian blue/alizarin red staining. Furthermore, long bones of the talpid(3) chick mutant did not express Phospho1 or Tnap whereas flat bones mineralized normally and expressed both phosphatases. In conclusion, this study has disclosed that PHOSPHO1 expression mirrors that of TNAP during embryonic bone development and that PHOSPHO1 contributes to bone mineralization in developing chick long bones.
PHOSPHO1 是一种骨特异性磷酸酶,参与无机磷酸盐的产生,从而启动基质矿化。矿化的控制归因于组织非特异性碱性磷酸酶(TNAP)的作用。然而,含磷灰石晶体的基质小泡(MVs)不仅存在于低磷酸酶血症患者中,也存在于 TNAP 缺失(Akp2(-/-))小鼠中。因此,其他磷酸酶可能与 TNAP 一起工作以调节基质矿化。尽管 PHOSPHO1 和 TNAP 的表达与 MVs 相关,但尚不清楚 PHOSPHO1 和 TNAP 是否在肢体发育的早期阶段共同表达。此外,PHOSPHO1 在基质矿化中的功能的体内作用尚未确定。在这里,我们研究了 PHOSPHO1 在鸡肢芽间充质微团培养物中的时空表达及其在野生型和 talpid(3)鸡突变体中的功能作用。这些突变体的特征是 hedgehog 信号传导缺陷和软骨内矿化缺失。体外微团培养物分化和矿化其基质的能力与 PHOSPHO1 和 TNAP 的表达增加呈时间相关。在发育中的胚胎腿部(发育阶段 23-36HH)中也观察到类似的表达变化。用兰索拉唑(PHOSPHO1 活性的小分子抑制剂)或 FGF2(软骨细胞分化抑制剂)处理微团培养物会导致茜素红染色减少(P<0.05)。FGF2 处理还导致 PHOSPHO1(P<0.001)和 TNAP(P<0.001)表达减少。通过整体 RNA 原位杂交的表达分析与 qPCR 微团数据相关,并证明存在一个紧密调控的 Phospho1 和 Tnap 表达模式,该模式先于矿化。用兰索拉唑处理发育中的胚胎 5 天,通过茜素红/阿利新蓝染色完全抑制所有腿部和翅膀长骨的矿化。此外,talpid(3)鸡突变体的长骨不表达 Phospho1 或 Tnap,而扁平骨正常矿化并表达两种磷酸酶。总之,本研究表明,PHOSPHO1 的表达在胚胎骨发育过程中与 TNAP 相吻合,并且 PHOSPHO1 有助于发育中的鸡长骨的骨矿化。